IL6 and COVID-19: The hallmark immunological characteristic of severe COVID‐19 is the cytokine imbalance, whereby strong pro‐inflammatory cues (e.g., mediated by elevated IL‐6) are accompanied by only minor activation of innate antiviral defenses (e.g., mediated by type I IFNs) leading to deleterious systemic response (Blanco‐Melo et al, 2020).